Thursday, January 07, 2021 11:32:35 AM
Hello JohnCM - What company are you looking at for those numbers?
According to the company for fiscal Q1 2021:
*) Their net revenue was $67M.
*) Cash and cash equivalents was $169M at the end of fiscal Q1 2021, not $250M.
*) The adjusted EBITDA loss for Q1 2021 was $57.9 million as compared to $32.3 million in the prior quarter. I see where you got the $10.5M from (in the company management discussion) but adjusting an already adjusted non-gaap number is quite a bit of creative accounting.
They have missed the EBITDA goal for 3 quarters in a row now and changed their debt requirements to liquidity (i.e. dilution) instead of profitability.
everything can be found here:
https://investor.auroramj.com/investor-info/financial-reports/
https://assets.ctfassets.net/rhxhcf3cql1g/2DQO81rmfWFRtqngh05Ia0/c4fdd409f3ed6ee40ecaf3edd165dfa0/FS_2020.09.30.pdf
According to the company for fiscal Q1 2021:
*) Their net revenue was $67M.
*) Cash and cash equivalents was $169M at the end of fiscal Q1 2021, not $250M.
*) The adjusted EBITDA loss for Q1 2021 was $57.9 million as compared to $32.3 million in the prior quarter. I see where you got the $10.5M from (in the company management discussion) but adjusting an already adjusted non-gaap number is quite a bit of creative accounting.
They have missed the EBITDA goal for 3 quarters in a row now and changed their debt requirements to liquidity (i.e. dilution) instead of profitability.
everything can be found here:
https://investor.auroramj.com/investor-info/financial-reports/
https://assets.ctfassets.net/rhxhcf3cql1g/2DQO81rmfWFRtqngh05Ia0/c4fdd409f3ed6ee40ecaf3edd165dfa0/FS_2020.09.30.pdf
"Sometimes people don't want to hear the truth because they don't want their illusions destroyed." - Friedrich Nietzsche
"None so deaf as those that will not hear. None so blind as those that will not see." - Matthew Henry
Recent ACB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2026 12:15:03 PM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (Canada) • 04/28/2026 10:53:00 AM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (US) • 04/28/2026 10:53:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/16/2026 08:18:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2026 11:21:53 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (Canada) • 04/15/2026 11:05:00 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (US) • 04/15/2026 11:05:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/30/2026 11:29:57 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (US) • 03/30/2026 11:03:00 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (Canada) • 03/30/2026 11:03:00 AM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (US) • 02/17/2026 11:39:00 PM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (Canada) • 02/17/2026 11:39:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2026 09:26:03 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (US) • 02/12/2026 09:05:00 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (Canada) • 02/12/2026 09:05:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (Canada) • 02/11/2026 12:00:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (US) • 02/11/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 09:44:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 02:45:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:27:19 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 02/04/2026 12:10:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:05:38 PM
- Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program • PR Newswire (Canada) • 02/04/2026 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2026 Third Quarter Results • PR Newswire (Canada) • 02/04/2026 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2026 Third Quarter Results • PR Newswire (US) • 02/04/2026 12:00:00 PM
